tosufloxacin has been researched along with Cerebral Nocardiosis in 1 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yazawa, K | 1 |
| Mikami, Y | 1 |
| Uno, J | 1 |
1 other study available for tosufloxacin and Cerebral Nocardiosis
| Article | Year |
|---|---|
In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262).
Topics: 4-Quinolones; Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyr | 1989 |